DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,995,982 | +16.5% | 294,220 | +12.7% | 0.32% | +17.9% |
| Q2 2023 | $62,673,120 | +11.1% | 261,138 | +16.7% | 0.27% | -11.1% |
| Q1 2023 | $56,419,406 | +356.2% | 223,851 | +380.4% | 0.31% | +403.3% |
| Q4 2022 | $12,367,776 | +317.8% | 46,597 | +306.6% | 0.06% | +335.7% |
| Q3 2022 | $2,960,000 | -27.9% | 11,460 | -29.2% | 0.01% | -22.2% |
| Q2 2022 | $4,104,000 | -68.0% | 16,190 | -63.0% | 0.02% | -59.1% |
| Q1 2022 | $12,841,000 | -72.5% | 43,778 | -69.2% | 0.04% | -55.6% |
| Q4 2021 | $46,747,000 | +9.4% | 142,083 | +1.2% | 0.10% | -5.7% |
| Q3 2021 | $42,723,000 | +10.6% | 140,334 | -2.5% | 0.10% | +25.0% |
| Q2 2021 | $38,641,000 | -76.7% | 143,990 | -80.5% | 0.08% | -79.5% |
| Q1 2021 | $165,914,000 | -5.3% | 737,133 | -6.6% | 0.41% | -12.2% |
| Q4 2020 | $175,258,000 | +202.7% | 788,951 | +193.5% | 0.47% | +7.4% |
| Q3 2020 | $57,891,000 | +76.6% | 268,847 | +45.0% | 0.43% | +65.0% |
| Q2 2020 | $32,776,000 | +5186.5% | 185,354 | +4040.1% | 0.26% | +3657.1% |
| Q1 2020 | $620,000 | -98.7% | 4,477 | -98.5% | 0.01% | -96.5% |
| Q4 2019 | $46,095,000 | – | 300,335 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |